Agfa-gevaert Nv · EURONEXT:AGFB
Agfa-gevaert Nv — H1 2013 Earnings Presentation
18 slides from Agfa-gevaert Nv's earnings presentation, Aug 28, 2013
Slide 1: Q2 and First Half 2013 Results
Q2 and First Half 2013 Results 28 August 2013
Slide 2: Profit & Loss: Key Figures (in million Euro)
Profit & Loss: Key Figures (in million Euro) Q2'12 Q2'13 Δ% H1'12 H1'13 Δ% (excl. X-rate) (excl. X-rate) Sales 779 732 -6.0% (-4.6%) 1,513 1,437 -5.0% (-3.9%) Gross Profit* 226 211 -6.6% 434 414 -4.6% as a % of sales 29.0% 28.8% 28.7% 28.8% SG&A* -147 -137 -6.8% -291 -277 -4.8% SG&A as % of sales 18
Slide 3: Net Financial Debt (in million Euro)
Net Financial Debt (in million Euro) 661 569 500 445 434 391 398 313 339 337 299 267 291 306 295 291 161 189 09 09 09 09 10 10 10 11 11 11 11 12 12 12 12 13 13 0 21 1' 2' 3' 4' 1' 3' 4' 1' 2' 3' 4' 1' 2' 3' 4' 1' 2' Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q 3
Slide 4: Working Capital: Key Figures (in million Euro/days)
Working Capital: Key Figures (in million Euro/days) 800 Inventories 800 Trade Receivables* 800 Trade Payables 700 717719 711 700 700 688 688 691 686 600 627 639 635 648 600 600 591 585 583 577 543 539 500 514 500 521532 527 500 483 482 496 476 487482 498484 469473471 467 438 452 452 400 400 400 300
Slide 5: Main Group Drivers behind Key Figures
Main Group Drivers behind Key Figures Q2 2013 • Group revenue impacted by the weak economic conditions and the decline of the classic film businesses • Agfa HealthCare’s digital radiography business performed strongly • Gross profit margin stable, while product portfolio rationalization contributed
Slide 6: Profit & Loss: Key Figures (in million Euro)
Profit & Loss: Key Figures (in million Euro) Restructuring and non-recurring -11 31 -21 22 Operating result 21 67 32 79 Non-operating result -20 -21 -44 -37 Profit before taxes 1 46 -12 42 Taxes 1 -23 -6 -31 Net result 2 23 -18 11 of which attr to owners of the company 0 21 -21 8 of which attr to no
Slide 7: Graphics
Graphics AGFA &
Slide 8: Graphics: Key Figures (in million Euro)
Graphics: Key Figures (in million Euro) Q2'12 Q2'13 Δ% H1'12 H1'13 Δ% (excl. curr.) (excl. curr. ) Sales 418 380 -9.1% (-7.8%) 814 751 -7.7% (-6.8%) Gross Profit* 108 97 -10.2% 208 190 -8.7% as a % of sales 25.8% 25.5% 25.6% 25.3% SG&A* -82 -73 -11.0% -161 -148 -8.1% as % of sales 19.6% 19.2% 19.8%
Slide 9: Graphics: Main Drivers behind Key Figures
Graphics: Main Drivers behind Key Figures Q2 2013 • Agfa Graphics’ revenue was impacted by the though economic conditions and the adverse currency effects • Volumes in digital prepress were stable, whereas the analog prepress business declined strongly • The industrial inkjet segment’s revenue was i
Slide 10: Graphics: YTD Sales per Business Segment
Graphics: YTD Sales per Business Segment 1H 2013 100% = 751 million Euro Inkjet, Software, Service 17% Analog Prepress 17% Digital Prepress 66% 10
Slide 11: HealthCare
HealthCare AGFA &
Slide 12: HealthCare: Key Figures (in million Euro)
HealthCare: Key Figures (in million Euro) Q2'12 Q2'13 Δ% H1'12 H1'13 Δ% (excl. curr.) (excl. curr. ) Sales 300 294 -2.0% (-0.6%) 578 570 -1.4% (+0.0%) Gross Profit* 109 102 -6.4% 209 199 -4.8% as a % of sales 36.3% 34.7% 36.0% 34.9% SG&A* -59 -58 -1.7% -117 -117 0.0% as % of sales 19.7% 19.7% 20.2%
Slide 13: HealthCare: Main Drivers behind Key Figures
HealthCare: Main Drivers behind Key Figures Q2 2013 • Excluding currency effects, Agfa HealthCare’s revenue remained almost stable • In the Imaging segment, the digital radiography business performed strongly. The traditional X-ray segment’s revenue decreased considerably. • The IT segment’s revenue
Slide 14: HealthCare: YTD Sales per Business Segment
HealthCare: YTD Sales per Business Segment 1H 2013 100% = 570 million Euro Hardcopy 29% Classic Radiology 11% CR/Modalities 19% Imaging IT* HIS/CIS 28% 13% HealthCare IT = 41% * Includes Radiology and Cardiology IT 14
Slide 15: Specialty Products
Specialty Products AGFA &
Slide 16: Specialty Products: Key Figures (in million Euro)
Specialty Products: Key Figures (in million Euro) Δ% Δ% Q2 '12 Q2 '13 (excl. curr.) H1'12 H1'13 (excl. curr.) Sales 61 58 -4.9% (-4.3%) 121 116 -4.1% (-3.7%) Gross profit* 9 12 33.3% 17 25 47.1% as a % of sales 14.8% 20.7% 14.2% 21.6% SG&A* -7 -6 -14.3% -13 -12 -7.7% as a % of sales 11.5% 10.3% 10.8
Slide 17: Specialty Products: Main Drivers behind Key Figures
Specialty Products: Main Drivers behind Key Figures Q2 2013 • The Synaps Synthetic Paper business, the Orgacon Electronic Materials business, the Security business and the PCB business performed well • Revenue was also influenced by the first effects of the supply agreement for microfilm signed with
Slide 18: Q&A
Q&A AGFA &